Products | DC Chemicals

Cat. No.	Product name	CAS No.
DCG-035	Licochalcone C >98%,Standard References	144506-14-9
DCQ-010	Notopterol >98%,Standard References	88206-46-6
DCE-021	Dihydrocurcumin >98%,Standard References	76474-56-1
DCE-026	β,β-dimethyl-acry-lalkannin >98%,Standard References	34539-65-6
DCX-019	Fargesin >98%,Standard References	31008-19-2
DCE-035	β,β-Dimethylacrylshikonin >98%,Standard References	24502-79-2
DCL-008	barbaloin >98%,Standard References	1415-73-2
DCG-009	Liquiritin >98%,Standard References	551-15-5
DCB-059	Allocryptopine >98%,Standard References	485-91-6
DCA-018	Raubasine >98%,Standard References	483-04-5
DCY-029	Phloridzin >98%,Standard References	7061-54-3
DCS-095	Tetrahydrocucumin >98%,Standard References	36062-04-1
DCM-046	Albaspidin AA >98%,Standard References	3570-40-9
DCT-026	Rhaponticin >98%,Standard References	155-58-8
DCL-033	Rotundine >98%,Standard References	10097-84-4
DCY-126	D-Tetrahydropalmatine >98%,Standard References	3520-14-7
DCZ-273	Demecolcine >98%,Standard References	477-30-5
DCZ-128	TETRAHYDROPALMATINE HYDROCHLORIDE >98%,Standard References	6024-85-7
DCY-019	Isorhychophylline >98%,Standard References	6859-01-4
DCL-021	Catharanthine Sulfate >98%,Standard References	70674-90-7
DCH-027	Sec-O-Glucosylhamaudol >98%,Standard References	80681-44-3
DCY-178	Acegastrodine >98%,Standard References	64291-41-4
DCR-031	Myrislignan >98%,Standard References	171485-39-5
DCY-016	Yohimbine hydrochloride Featured Yohimbine hydrochloride is an alpha-2 renal adenomatase receptor inhibitor, blocking pre- and post-contact alpha-2 renal adenomatase receptors, causing the release of renal adenoma and multiple sclerosis.	65-19-0
DCD-046	Scopolamine butylbromide >98%,Standard References	149-64-4
DCH-026	Progesterone >98%,Standard References	57-83-0
DCH-055	Pinusolide >98%,Standard References	31685-80-0
DCD-083	RhMannioside A >98%,Standard References	81720-05-0
DCZ-269	Melittoside >98%,Standard References	19467-03-9
DCZ-230	Rehmannioside C >98%,Standard References	81720-07-2
DCJ-037	10-Gingerol >98%,Standard References	23513-15-7
DCC-052	Atractyloside A >98%,Standard References	126054-77-1
DCS-041	Sudan III；Solvent Red 23 >98%,Standard References	85-86-9
DCY-165	Ethoxysanguinarine >98%,Standard References	28342-31-6
DCB-022	(-)-Epicatechin gallate >98%,Standard References	1257-08-5
DCM-059	(-)-Gallocatechin gallate >98%,Standard References	4233-96-9
DCB-023	(-)-Epigallocatechin gallate >98%,Standard References	989-51-5
DCJ-005	Cichoric acid >98%,Standard References	70831-56-0
DCZ-143	7-Ethylcamptothecin >98%,Standard References	78287-27-1
DCS-016	7-Ethyl-10-Hydroxy-Camptothecin >98%,Standard References	119577-28-5
DCQ-046	Oroxyloside >98%,Standard References	36948-76-2
DCS-061	Trifolirhizin >98%,Standard References	6807-83-6
DCH-017	Glycitin >98%,Standard References	40246-10-4
DCM-020	Calycosin-7-O-beta-D-glucoside >98%,Standard References	20633-67-4
DCJ-017	3’- Methoxy Puerarin >98%,Standard References	117047-07-1
DCX-033	Diosmetin-7-O-β-D-glucopyranoside >98%,Standard References	20126-59-4
DCS-026	Tectoridin >98%,Standard References	611-40-5
DCY-137	Isorhamnetin-3-O-galactoside >98%,Standard References	6743-92-6
DCY-080	Isorhamnetin-3-O-β-D-Glucoside >98%,Standard References	5041-82-7
DCB-044	Praeruptorin C >98%,Standard References	72463-77-5
DCG-007	Podophyllotoxin >98%,Standard References	518-28-5
DCM-013	Ononin >98%,Standard References	486-62-4
DCJ-049	4'-O-Methylpuerarin >98%,Standard References	92117-94-7
DCT-033	Dehydrocorydaline >98%,Standard References	30045-16-0
DCW-009	Schisandrin C >98%,Standard References	61301-33-5
DCQ-083	3,5,6,7,8,3’,4’-heptemthoxyflavone 3,5,6,7,8,3',4'-Heptemthoxyflavone, a flavonoid from satsuma peel, is an orally available CREB activator with anti-tumor and anti-neuroinflammatory activity. 3,5,6,7,8,3',4'-Heptemthoxyflavone inhibits collagenase activity and increases the content of type I procollagen in human dermal fibroblast neoblast (HDFn) cells. 3,5,6,7,8,3',4'-Heptemthoxyflavone induces brain-derived neurotrophic factor (BDNF) expression through the cAMP/ERK/CREB signaling pathway and reduces phosphodiesterase activity in C6 glioma.	1178-24-1
DCY-010	Isocorynoxeine >98%,Standard References	51014-29-0
DCQ-081	Corynoxeine >98%,Standard References	630-94-4
DCM-041	Agnuside >98%,Standard References	11027-63-7
DCX-023	Curculigoside >98%,Standard References	85643-19-2
DCD-059	DL-Syringaresinol >98%,Standard References	1177-14-6
DCM-047	Albaspidin AP >98%,Standard References	59092-91-0
DCY-158	Corydaline >98%,Standard References	518-69-4
DCK-020	Corynoxine >98%,Standard References	6877-32-3
DCZ-255	Corynoxine B >98%,Standard References	17391-18-3
DCG-017	Rhynchophylline >98%,Standard References	76-66-4
DCJ-002	5-O-Methylvisammioside >98%,Standard References	84272-85-5
DCW-005	Schisandrin A >98%,Standard References	61281-38-7
DCG-060	Gomisin J >98%,Standard References	66280-25-9
DCT-018	pseudolaric acid A >98%,Standard References	82508-32-5
DCY-135	Bullatine G >98%,Standard References
DCK-010	Blinin >98%,Standard References	125675-09-4
DCY-099	Bullatine A >98%,Standard References	1354-84-3
DCG-044	denudatine >98%,Standard References	26166-37-0
DCD-021	Tuberostemonine >98%,Standard References	6879-01-2
DCQ-036	Troxerutin >98%,Standard References	7085-55-4
DCZ-144	ROTENONE >98%,Standard References	83-79-4
DCT-030	Topotecan >98%,Standard References	123948-87-8
DCY-154	5-Ethoxychelerthrine >98%,Standard References	79559-55-0
DCY-077	Acetylcorynoline >98%,Standard References	18797-80-3
DCY-048	Topotecan hydrochloride Featured Topotecan Hydrochloride (SKF 104864A Hydrochloride) is a Topoisomerase I inhibitor with potent antineoplastic activities.	119413-54-6
DCD-082	γ- Mangostin >98%,Standard References	31271-07-5
DCM-053	Brucine >98%,Standard References	357-57-3
DCM-051	Calceorioside B >98%,Standard References	105471-98-5
DCG-016	Glibenclamide >98%,Standard References	10238-21-8
DCS-011	Albiflorin >98%,Standard References	39011-90-0
DCS-010	Paeoniflorin >98%,Standard References	23180-57-6
DCQ-019	oxypaeoniflorin >98%,Standard References	39011-91-1
DCH-008	Picroside Ⅱ >98%,Standard References	39012-20-9
DCW-001	Schisandrin B >98%,Standard References	61281-37-6
DCM-031	magnolin >98%,Standard References	31008-18-1
DCT-009	Pseudolaric Acid B >98%,Standard References	82508-31-4
DCY-125	Protostemotinine >98%,Standard References	169534-85-4
DCW-034	Schisanhenol >98%,Standard References	69363-14-0
DCS-042	Sudan IV；Solvent Red 24 >98%,Standard References	85-83-6
DCY-092	iridin >98%,Standard References	491-74-7
DCY-180	3-isomangostin >98%,Standard References	19275-46-8
DCS-073	Mulberroside C >98%,Standard References	102841-43-0
DCH-007	PicrosideⅠ >98%,Standard References	27409-30-9
DCO-002	Levistilide A >98%,Standard References	88182-33-6
DCB-087	Praeruptorin E >98%,Standard References	78478-28-1
DCH-020	Harpagoside >98%,Standard References	19210-12-9
DCY-155	Eupalinolide B Featured >98%,Standard References	877822-41-8
DCC-048	Acevaltrate >98%,Standard References	25161-41-5
DCZ-041	Resibufogenin >98%,Standard References	465-39-4
DCS-068	Bufarenogin >98%,Standard References	17008-69-4
DCZ-115	Schisandrin >98%,Standard References	7432-28-2
DCY-164	Telocinobufagin >98%,Standard References	472-26-4
DCR-041	Gamabufotalin >98%,Standard References	465-11-2
DCR-033	Gamabufalin >98%,Standard References
DCN-019	Neoline，Bullatine B >98%,Standard References	466-26-2
DCZ-028	Hyodeoxycholic acid >98%,Standard References	83-49-8
DCQ-013	Deoxycholic acid >98%,Standard References	83-44-3
DCX-027	Ursodeoxycholic acid >98%,Standard References	128-13-2
DCD-045	Cholic acid >98%,Standard References	81-25-4
DCN-016	Nystose >98%,Standard References	13133-07-8
DCC-074	Hydnocarpin >98%,Standard References	51419-48-8
DCS-024	Silibinin >98%,Standard References	22888-70-6
DCS-072	Morusin >98%,Standard References	62596-29-6
DCY-055	polygalaxanthone III >98%,Standard References	162857-78-5
DCX-032	neomangiferin >98%,Standard References	64809-67-2
DCL-041	Picroside III >98%,Standard References	64461-95-6
DCW-003	Vindoline >98%,Standard References	2182-14-1
DCC-061	Chasmanine >98%,Standard References	5066-78-4
DCY-123	delsoline >98%,Standard References	509-18-2
DCW-015	Aconine >98%,Standard References	509-20-6
DCD-070	Salvianolicacid C >98%,Standard References	115841-09-3
DCQ-077	Apiin >98%,Standard References	26544-34-3
DCX-029	Schaftoside >98%,Standard References	51938-32-0
DCY-153	Isoschaftoside >98%,Standard References	52012-29-0
DCQ-093	Isoliquiritin apioside >98%,Standard References	120926-46-7
DCH-023	obacunone >98%,Standard References	751-03-1
DCN-006	Limonin >98%,Standard References	1180-71-8
DCS-032	mulberroside A >98%,Standard References	102841-42-9
DCC-058	Bufotaline >98%,Standard References	471-95-4
DCN-018	Taurochenodeoxycholic Acid >98%,Standard References	516-35-8
DCN-014	Tauroursodeoxycholic acid Featured Tauroursodeoxycholate (Tauroursodeoxycholic acid) is an endoplasmic reticulum (ER) stress inhibitor. Tauroursodeoxycholate significantly reduces expression of apoptosis molecules, such as caspase-3 and caspase-12. Tauroursodeoxycholate also inhibits ERK.	14605-22-2
DCZ-008	lithospermic acid >98%,Standard References	28831-65-4
DCB-063	baohuoside I >98%,Standard References	113558-15-9
DCY-150	Icarisid I >98%,Standard References
DCY-106	Rhoifolin >98%,Standard References	17306-46-6
DCS-062	Kaempferitrin >98%,Standard References	482-38-2
DCM-038	Vitexin rhamnoside >98%,Standard References	64820-99-1
DCM-039	glucosylvitexin >98%,Standard References	76135-82-5
DCS-065	Kaempferol-3-O-rutinoside >98%,Standard References	17650-84-9
DCM-002	Oroxin B >98%,Standard References	114482-86-9
DCS-108	Kaempferol-3-O-sophoroside >98%,Standard References	19895-95-5
DCH-070	Rhodiosin; Herbacetin-7-O-glucorhamnoside >98%,Standard References	86831-54-1
DCL-001	Rutin >98%,Standard References	153-18-4
DCY-071	Narirutin >98%,Standard References	14259-46-2
DCY-006	Naringin >98%,Standard References	10236-47-2
DCS-006	Eriocitrin >98%,Standard References	13463-28-0
DCQ-008	Hydroxysafflor yellow A >98%,Standard References	78281-02-4
DCG-021	Gliquidone >98%,Standard References	33342-05-1
DCL-073	Thiocolchicoside >98%,Standard References	602-41-5
DCL-010	Forsythin >98%,Standard References	487-41-2
DCL-052	Tracheloside >98%,Standard References	33464-71-0
DCX-026	Naringin dihydrochalcone >98%,Standard References	18916-17-1
DCZ-151	Ipecoside >98%,Standard References	15401-60-2
DCZ-127	NEORUSCOGENIN >98%,Standard References	17676-33-4
DCB-030	peimisine >98%,Standard References	19773-24-1
DCD-069	deltaline >98%,Standard References	6836-11-9
DCC-059	Bonvalotidine A Bonvalotidine A is a lycoctonine-type C19-diterpenoid alkaloid isolated from the roots of Delphinium bonvalotii Franch.	929019-25-0
DCD-084	RhMannioside D >98%,Standard References	81720-08-3
DCF-026	Saponin >98%,Standard References	8047-15-2
DCS-005	Diosgenin >98%,Standard References	512-04-9
DCY-117	yamogenin >98%,Standard References	512-06-1
DCH-033	Hecogenin >98%,Standard References	467-55-0
DCL-009	Ruscogenin >98%,Standard References	472-11-7
DCA-009	solasodine >98%,Standard References	126-17-0
DCB-007	Peiminine >98%,Standard References	18059-10-4
DCX-021	Imperialine >98%,Standard References	61825-98-7
DCZ-116	Vitamin D3 >98%,Standard References	67-97-0
DCJ-024	Tigogenin >98%,Standard References	77-60-1
DCZ-063	Gitogenin >98%,Standard References	511-96-6
DCT-004	Crustecdysone Featured Crustecdysone (20-Hydroxyecdysone) is a naturally occurring ecdysteroid hormone isolated from Serratula coronata which controls the ecdysis (moulting) and metamorphosis of arthropods, it inhibits caspase activity and induces autophagy via the 20E nuclear receptor complex, EcR-USP. Crustecdysone exhibits regulatory or protective roles in the cardiovascular system. Crustecdysone is an active metabolite of Ecdysone (HY-N0179).	5289-74-7
DCS-059	Hupehenine >98%,Standard References	98243-57-3
DCB-006	Peimine >98%,Standard References	23496-41-5
DCD-041	Cholesterol Featured Cholesterol is a component of Lipid nanoparticles (LNPs) for RNA delivery.	57-88-5
DCM-005	2”-O-Galloylhyperin >98%,Standard References	53209-27-1
DCL-026	Rhodamine B >98%,Standard References	81-88-9
DCM-009	Linarin >98%,Standard References	480-36-4
DCD-005	Diosmin >98%,Standard References	520-27-4
DCS-043	Spinosin >98%,Standard References	72063-39-9
DCY-075	Isorhamnetin-3-O-nehesperidine >98%,Standard References	55033-90-4
DCS-066	Complanatoside A >98%,Standard References	146501-37-3
DCS-063	Narcissoside >98%,Standard References	604-80-8
DCS-051	complanatuside >98%,Standard References	116183-66-5
DCG-019	Poncirin >98%,Standard References	14941-08-3
DCX-034	didymin >98%,Standard References	14259-47-3
DCX-010	Neohesperidin >98%,Standard References	13241-33-3
DCD-063	Angeloylisogomisin O >98%,Standard References	83864-70-4
DCL-023	nomilin >98%,Standard References	1063-77-0
DCC-019	Kalii Dehydrographolidi Succinas Kalii Dehydrographolidi Succinas (Potassium dehydroandrographolide succinate), extracted from herbal medicine Andrographis paniculata (Burm f) Nees, is widely used for the treatment of viral pneumonia and viral upper respiratory tract infections because of its immunostimulatory, anti-infective and anti-inflammatory effect.	76958-99-1
DCT-013	Dehydroandrographolidesuccinate >98%,Standard References	786593-06-4
DCW-027	Eleutheroside E1 >98%,Standard References	7374-79-0
DCX-004	Neosperidin dihydrochalcone >98%,Standard References	20702-77-6
DCQ-024	Qingyangshengenin A >98%,Standard References	84745-94-8
DCS-117	Harringtonine >98%,Standard References	26833-85-2
DCD-060	Macrocarpal B >98%,Standard References	142698-60-0